Trial Profile

First-in-Human Dose-Escalation Study of TEW-7197 Monotherapy in Subjects With Advanced Stage Solid Tumors

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vactosertib (Primary)
Indications Solid tumours
Focus Adverse reactions; First in man
Sponsors MedPacto

Most Recent Events

13 Jul 2019 Results assessing pharmacokinetic characteristics of vactosertib in patients with advanced solid tumours published in the Investigational New Drugs
08 May 2019 Status changed from active, no longer recruiting to completed.
16 Mar 2019 Results characterizing the population pharmacokinetics (Pop PK) of vactosertib in patients with advanced- stage solid tumors, presented at the 120th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com